During the past decade, Hopital Jean Verdier conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 2 clinical trials were completed, i.e. on average, 8.7% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hopital Jean Verdier" #1 sponsor was "Assistance Publique - Hôpitaux de Paris" with 13 trials, followed by "ANRS, Emerging Infectious Diseases" with 8 trials sponsored, "Centre Hospitalier Intercommunal Creteil" with 2 trials sponsored, "Centre Hospitalier Universitaire de Besancon" with 2 trials sponsored and "Cytheris SA" with 2 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital Jean Verdier" #1 collaborator was "National Cancer Institute, France" with 3 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Institut National de la Santé Et de la Recherche Médicale, France" with 2 trials as a collaborator, "Janssen-Cilag Ltd." with 2 trials as a collaborator and "Merck Sharp & Dohme LLC" with 2 trials as a collaborator. Other collaborators include 20 different institutions and companies that were collaborators in the rest 29 trials.

According to Clinical.Site data, the most researched conditions in "Hopital Jean Verdier" are "Cirrhosis" (4 trials), "Breast Cancer" (3 trials), "HIV Infections" (3 trials), "HIV-1 Infection" (3 trials) and "HIV Infection" (2 trials). Many other conditions were trialed in "Hopital Jean Verdier" in a lesser frequency.

Most popular intervention types in "Hopital Jean Verdier" are "Drug" (27 trials), "Other" (10 trials), "Procedure" (8 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Interleukin-7" (2 trials), "Rifaximin" (2 trials), "0.9% Normal Saline" (1 trials) and "3% Saline" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Jean Verdier" are 37 trials for "All" genders, 8 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Hopital Jean Verdier". undefined are not yet recruiting, 7 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Hopital Jean Verdier, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Jean Verdier, 2 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 11 trials that are defined as “Not Applicable".

Hopital Jean Verdier has several departments that took part in Clinical trials: "Hopital Avicenne; Neurologie" - 4 trials, "Virologie - Hôpital Avicenne" - 2 trials